Transforming Global Health Through  Precision Bio-Therapeutics


SHC Therapeutics is a pre-clinical biopharmaceutical company developing next-generation bio-therapeutics using our proprietary Genomic RNA Packaging Enhancement (GRPE) platform to delivery targeted therapies. 


We are uniquely positioned to develop personalized and precision bio-therapeutics across a broad range of disease areas and have a lead candidate at the pre-clinical phase utilizing our core technology.



Leveraging GRPE to create targeted treatments across a broad range of applications


HIV

RSV

EBV

Zoster